JOINT FILING AGREEMENT
Exhibit 99
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13G with respect to the Common Shares beneficially owned by each of them of Merus N.V. This Joint Filing Agreement shall be included as an Exhibit to such Schedule 13G.
IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 3rd day of June, 2016.
| Novartis Bioventures Ltd. | ||
| /s/ Xxxxx Xxxx | ||
| Name: | Xxxxx Xxxx | |
| Title: | Chairman | |
| /s/ Xxxxxxxxx Xxxxxxxxxx | ||
| Name: | Xxxxxxxxx Xxxxxxxxxx | |
| Title: | Authorized Signatory | |
| Novartis AG | ||
| /s/ Xxxxx Xxxx | ||
| Name: | Xxxxx Xxxx | |
| Title: | Authorized Signatory | |
| /s/ Xxxxxxxxx Xxxxxxxxxx | ||
| Name: | Xxxxxxxxx Xxxxxxxxxx | |
| Title: | Authorized Signatory | |
